Medical Condition News

RSS

Molecular subtyping provides insights into how to treat breast cancer

New evidence showing that the MammaPrint® and BluePrint® tests provide insights into how to treat breast cancer was presented at the annual conference of the American Society of Breast Surgeons (ASBrS).

7 May 2014

Research on how heart rate increases in response to alertness in brain

George Washington University (GW) researcher David Mendelowitz, Ph.D., was recently published in the Journal of Neuroscience for his research on how heart rate increases in response to alertness in the brain.

7 May 2014

First reversible glue to treat eye injuries of soldiers

Scientists have developed the first reversible glue that could be used on the battlefield to treat eye injuries, potentially saving soldiers' vision. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Orlando, Fla.

7 May 2014

Perfusion system at room temperature preserves and improves metabolic function of donor livers

A system developed by investigators at the Massachusetts General Hospital (MGH) Center for Engineering in Medicine (CEM) and the MGH Transplant Center has the potential to increase both the supply and the quality of donor organs for liver transplantation.

7 May 2014

New action plan identifies key priorities for diabetes care in the UK

A new action plan announced today by Novo Nordisk and collaborative partners at the Diabetes UK conference has identified improved self-management, structured education and psychological support as key priorities for diabetes care in the UK.

7 May 2014

Regression occurs more often in black and Hispanic children compared to whites

Some children with autism appear to be developing normally when they are very young. They babble or even talk, make eye contact with their parents, and crawl and walk on schedule. Then suddenly, these skills seem to vanish.

7 May 2014

Johns Hopkins to use $65 million gift to expand Sidney Kimmel Comprehensive Cancer Center

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins will use a $65 million gift toward the construction of a new patient care building that will be named for the late Albert P. “Skip” Viragh, Jr., a Maryland mutual fund investment leader and philanthropist.

7 May 2014

RPCI research finds patients with metastatic kidney cancer benefit from HDIL-2 immunotherapy

A retrospective study published online ahead of print in the medical journal Urology by a physician team from Roswell Park Cancer Institute (RPCI) found that patients with metastatic kidney cancer — even those with chronic renal insufficiency — can tolerate and benefit from a treatment called high-dose interleukin-2 (HDIL-2) immunotherapy.

7 May 2014

Study focuses on mutated protein associated with early onset torsion dystonia

A collaborative discovery involving Kansas State University researchers may lead to the first universal treatment for dystonia, a neurological disorder that affects nearly half a million Americans.

7 May 2014

Socioeconomic standing within community can help predict risk of cardiovascular disease

How a person defines their own socioeconomic standing (SES) within their community can help predict their risk of cardiovascular disease, but only among Whites, not Blacks, finds a recent study in Ethnicity and Disease.

7 May 2014

New research focuses on using wheat fiber to lower cholesterol and prevent development of heart disease

The saying, "we are what we eat," has never been more true. Nutritionists increasingly emphasize that the nutrients in the foods we consume can potentially create health and reduce disease.

7 May 2014

Exelixis presents final Phase 1b data on investigational MEK-BRAF inhibitor combination therapy for metastatic melanoma

Exelixis, Inc. today announced final results from BRIM7, an ongoing phase 1b clinical trial conducted by Roche and Genentech, Exelixis' collaborator and a member of the Roche Group, of the BRAF inhibitor (BRAFi) vemurafenib in combination with the MEK inhibitor cobimetinib in patients with locally advanced/unresectable or metastatic melanoma carrying a BRAFV600 mutation.

7 May 2014

NanoString receives license from Health Canada to market Prosigna Breast Cancer Prognostic Gene Signature Assay

NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced that it has received a Class III Medical Device License from Health Canada, clearing the company to market its Prosigna Breast Cancer Prognostic Gene Signature Assay for assessing a woman's 10-year risk of distant recurrence and accurately identifying the intrinsic biologic subtype of the tumor.

From NanoString Technologies 7 May 2014

New molecular "clamps" offer powerful new tool for identifying individuals with increased risk of cancer

An international research team has built molecular "clamps" out of DNA that offer a powerful new tool for identifying individuals with an increased risk of cancer.

7 May 2014

New research aids development of better treatments for dry eye

The eye is an exquisitely sensitive system with many aspects that remain somewhat of a mystery-both in the laboratory and in the clinic.

7 May 2014

Glial cells promise as new target to modulate retinal synaptic plasticity after retinal injury

Different types of retinal damage could induce plastic changes of retinal synapses, which might precede the serious damage of neuron soma.

7 May 2014

Scientists identify key molecular switches that control age-related memory impairment

Even among the healthiest individuals, memory and cognitive abilities decline with age. This aspect of normal aging can affect an individual's quality of life and capability to live independently but the rate of decline is variable across individuals.

7 May 2014

New research shows cataract surgery reduces number of falls in older patients

New research finds that cataract surgery dramatically decreases the number of falls individuals suffer due to poor vision.

7 May 2014

Social worker has potential to reduce functional decline of people with mild traumatic brain injury

More than a million people are treated for mild traumatic brain injuries in U.S. hospitals and emergency rooms each year. Yet few receive appropriate psychological and social follow-up care that can make the difference in whether or not they fully recover.

7 May 2014

Monthly injections to counteract AMD may not be necessary, say researchers

Researchers have found that, contrary to prvious clinical trial findings, monthly injections to counteract age-related macular degeneration (AMD) may not be necessary.

7 May 2014

Medical Condition News

Molecular subtyping provides insights into how to treat breast cancer

Research on how heart rate increases in response to alertness in brain

First reversible glue to treat eye injuries of soldiers

Perfusion system at room temperature preserves and improves metabolic function of donor livers

New action plan identifies key priorities for diabetes care in the UK

Regression occurs more often in black and Hispanic children compared to whites

Johns Hopkins to use $65 million gift to expand Sidney Kimmel Comprehensive Cancer Center

RPCI research finds patients with metastatic kidney cancer benefit from HDIL-2 immunotherapy

Study focuses on mutated protein associated with early onset torsion dystonia

Socioeconomic standing within community can help predict risk of cardiovascular disease

New research focuses on using wheat fiber to lower cholesterol and prevent development of heart disease

Exelixis presents final Phase 1b data on investigational MEK-BRAF inhibitor combination therapy for metastatic melanoma

NanoString receives license from Health Canada to market Prosigna Breast Cancer Prognostic Gene Signature Assay

New molecular "clamps" offer powerful new tool for identifying individuals with increased risk of cancer

New research aids development of better treatments for dry eye

Glial cells promise as new target to modulate retinal synaptic plasticity after retinal injury

Scientists identify key molecular switches that control age-related memory impairment

New research shows cataract surgery reduces number of falls in older patients

Social worker has potential to reduce functional decline of people with mild traumatic brain injury

Monthly injections to counteract AMD may not be necessary, say researchers

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News